What is POTS, a extensive explanation.

By

Update: Postural Orthostatic Tachycardia Syndrome (POTS)

Postural Orthostatic Tachycardia Syndrome (POTS) is a disorder of the autonomic nervous system, which regulates involuntary functions such as heart rate, blood pressure, circulation, and digestion. It is characterized by orthostatic intolerance and an excessive increase in heart rate after moving to an upright position, often accompanied by disabling multisystem symptoms.

POTS and Long COVID

Long COVID is associated with persistent autonomic dysfunction, including orthostatic intolerance and POTS. In a cross-sectional study of individuals with symptoms lasting at least four weeks after moderate COVID-19, beat-to-beat cardiovascular recordings and a novel geometric method were used to characterize baroreflex sensitivity (BRS).

During orthostasis, patients exhibited significantly lower BRS than healthy controls. Reduced BRS was associated with higher arterial blood pressure and heart rate, as well as lower heart-rate variability. The proposed method correlated with established heart-rate variability measures and was validated against the sequence method. These findings support BRS impairment as a spectrum-based marker of autonomic dysfunction that may improve the classification and diagnosis of patients with Long COVID and POTS-like symptoms.

Definition and diagnosis

POTS is generally identified by a sustained increase in heart rate of at least 30 beats per minute in adults—or 40 beats per minute in adolescents—within 10 minutes of standing or head-up tilt. This response occurs without the sustained blood-pressure decrease required for a diagnosis of orthostatic hypotension. Symptoms should be chronic, occur while upright, and not be better explained by another condition.

Assessment may include an active standing test or tilt-table test with continuous monitoring of heart rate and blood pressure. Additional investigations can help exclude dehydration, anemia, medication effects, endocrine disorders, cardiac disease, and other causes of orthostatic tachycardia.

Symptoms

Clinical presentation varies considerably and may fluctuate over time. Common symptoms include:

  • Dizziness, lightheadedness, fainting, or near-fainting
  • Tachycardia and palpitations
  • Fatigue and exercise intolerance
  • Headaches or migraines
  • Cognitive difficulties or “brain fog”
  • Nausea and gastrointestinal discomfort
  • Chest discomfort, weakness, sweating, and tremulousness

These symptoms can substantially affect daily functioning and quality of life.

Causes and mechanisms

POTS is a heterogeneous syndrome rather than a single disease. Symptoms may develop after a viral infection, surgery, physical trauma, pregnancy, or prolonged inactivity. Autoimmune processes, genetic susceptibility, reduced blood volume, autonomic nerve dysfunction, and abnormal sympathetic activation may contribute.

When a healthy person stands, blood vessels constrict and heart rate increases modestly to preserve blood flow to the brain. In POTS, impaired vascular regulation can permit blood to pool in the lower body, producing compensatory tachycardia and reduced tolerance of an upright posture. Both sympathetic “fight-or-flight” and parasympathetic “rest-and-digest” regulation may be affected.

Clinical phenotypes

Recognized POTS phenotypes overlap and should not always be regarded as distinct subtypes.

Neuropathic POTS involves partial autonomic nerve dysfunction, often affecting the lower limbs. Impaired vasoconstriction can promote blood pooling in the legs and abdomen.

Hyperadrenergic POTS is associated with excessive sympathetic activation and, in some patients, increased norepinephrine while standing. Features can include tachycardia, increased blood pressure, palpitations, tremor, sweating, flushing, migraines, and a physical sensation resembling anxiety or panic. Proposed contributors include central autonomic dysfunction and impaired norepinephrine clearance. Mast-cell activation symptoms may coexist in some individuals, although the relationship remains under investigation.

Other overlapping presentations may involve low circulating blood volume, impaired physical conditioning, or secondary POTS associated with another medical condition.

Treatment and prognosis

Management is individualized and may combine increased fluid intake, clinician-guided salt intake, compression garments, pacing, and a gradual recumbent-to-upright exercise program. Medications such as beta-blockers, midodrine, fludrocortisone, or other agents may be considered according to the patient’s symptoms and cardiovascular profile.

The course of POTS varies. Some patients improve substantially, while others experience persistent or fluctuating symptoms. Research is continuing into post-viral mechanisms, autoimmunity, microvascular regulation, baroreflex impairment, and altered energy metabolism. Anaerobic metabolism may contribute to exercise intolerance in some patients, but it is not currently a defining feature of POTS. Patients should be evaluated and managed by clinicians familiar with autonomic disorders.

Reference: 

Baroreflex sensitivity impairment in Long-COVID patients: a diagnostic tool for classifying the autonomic dysfunction spectrum
https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.1830347/full

Hyperadrenergic Postural Tachycardia Syndrome in Mast Cell Activation Disorders
https://www.ahajournals.org/doi/10.1161/01.hyp.0000158259.68614.40

Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome
https://pmc.ncbi.nlm.nih.gov/articles/PMC6015435/

What Is Hyperadrenergic POTS? Causes, Treatment & Recovery 4
https://int.livhospital.com/what-is-hyperadrenergic-pots-causes-treatment-recovery/ 

What is noradrenaline?
https://mhanational.org/resources/what-is-noradrenaline/

 

© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9 

Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

By
Acute flaccid myelitis (AFM) is a rare but serious neurological disorder that primarily affects children and results in sudden weakness or paralysis in the limbs. Often referred to as a “polio-like” illness, AFM has drawn growing attention over the past decade due to its similarities with poliomyelitis and its seasonal spikes in reported cases. While AFM remains uncommon, its potential severity—and the uncertainty surrounding its causes—make it an important condition for clinicians, parents, and public health officials to understand. What Is Acute Flaccid Myelitis? AFM is a condition that affects the gray matter of the spinal cord , where it damages motor neurons responsible for muscle movement. This leads to acute, flaccid paralysis , meaning muscles become limp and weak, often without warning. The condition can progress rapidly, and in some cases, the weakness can become long-lasting or even permanent. Although its symptoms resemble those of poliovirus infection, AFM is not cau...
Read more

Very Long-Chain Fatty Acids (VLCFAs) X-ALD and Spinal Muscular Atrophy (SMA): Exploring the Connection

By
Image
Introduction: White Brain Matter, VLCFAs, and X-ALD X-linked Adrenoleukodystrophy (X-ALD) is a rare inherited metabolic disorder and a major cause of progressive neurodegeneration in children—sometimes referred to as “childhood dementia.” Across related conditions, prevalence can range from approximately 1 in 2,000 to 1 in 500,000 newborns. Among its forms, childhood cerebral X-ALD is the most severe, marked by rapid inflammatory demyelination in the brain and often fatal outcomes if not treated early. At the core of X-ALD is a disruption in the metabolism of Very Long-Chain Fatty Acids (VLCFAs). Normally, these fatty acids are broken down in peroxisomes—specialized structures within cells that help maintain metabolic balance. In X-ALD, a mutation in the ABCD1 gene impairs this function, causing VLCFAs to accumulate, particularly in the white matter of the brain, spinal cord, and adrenal glands. This accumulation leads to demyelination, adrenal insufficiency (Addison’s disease), an...
Read more

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By
Image
Important update: My experiences have now been formally verified following several years of dismissal. Vasculitis syndromes: the pathogenic roles of COVID-19 and related vaccinations https://link.springer.com/article/10.1186/s12985-025-03032-x  ----------------------------------------- Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially pres...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more

Polio and Post-Polio Syndrome (PPS): Summary and Key Insights

By
Image
  Abstract To investigate the possible role of poliovirus (PV) infection in the development of Post-Polio Syndrome (PPS), researchers studied serum, cerebrospinal fluid (CSF), peripheral blood lymphocytes, and muscle tissue from 47 PPS patients. Elevated IgM antibodies against poliovirus were identified in a subset of patients, with titers reaching 1:250 compared with less than 1:50 in healthy individuals and disease controls. Using polymerase chain reaction (PCR) techniques targeting the poliovirus replicase gene, PV RNA sequences were detected in peripheral blood lymphocytes from 7 of 37 patients and in the CSF of 4 of 40 patients, while no viral sequences were detected in controls. Sequencing confirmed a 99.3% homology with poliovirus type 1. These findings suggest that some PPS patients may exhibit an ongoing immune response to poliovirus antigens. The detection of poliovirus RNA raises the possibility of persistent mutated virus or defective viral particles. However, the signi...
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By
Update: New Research Builds on Previous Findings Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2832234?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=wklyforyou&utm_term=040925&adv= Conclusions: This recent cohort study builds upon earlier work by identifying COVID-related cytokine storm (COVID-CS) through common inflammation markers and comparing it with two other cytokine storm (CS) conditions: malignancy-associated hemophagocytic lymphohistiocytosis (MN-HLH) and CAR-T–associated cytokine release syndrome (CAR-T CRS) . Among the three groups, patients treated with CAR-T therapy showed the highest survival rates , in contrast to those with COVID-CS and MN-HLH. Interestingly, the study found that CAR-T CRS and COVID-CS share similar cytokine activation pathways , suggesting a comparable immune response mechanism. In c...
Read more

The Impact of Acids on Muscular and Vascular Systems: Potential Negative Outcomes

By
This is ongoing research, and updates will be included as soon as they become available. A kidney transplant recipient with acute SARS-CoV-2 infection developed rhabdomyolysis and severe acute kidney injury (AKI) . A muscle biopsy confirmed findings consistent with immune-mediated necrotising myositis. Acid exposure and acid–base imbalances may profoundly affect the muscular and vascular systems. Strong acids from external sources, such as industrial chemicals, can cause corrosive tissue damage, while internal disturbances associated with metabolic disorders may disrupt cellular function and contribute to systemic complications. This article explores the potential effects of external acid exposure and internal acid–base disturbances on muscular and vascular health, including those associated with metabolic or genetic conditions. Because susceptibility to ME/CFS and complications following COVID-19 varies among individuals, further research may help determine whether genetic variant...
Read more

Introduction to Adenosine and Tachycardia

By
What is Adenosine? Adenosine is a chemical found in human cells, existing in three forms: adenosine, adenosine monophosphate (AMP), and adenosine triphosphate (ATP). Adenosine is a chemical found in the body that plays many roles, including influencing heart rate and promoting sleep and relaxation. It is also used as a medication to manage certain types of tachycardia, particularly supraventricular tachycardia. Adenosine works by slowing the heart rate through its action on the cardiac tissue. Adenosine production in the body occurs through multiple pathways: Phosphorylation of Adenine: Adenine can be directly phosphorylated to form AMP (adenosine monophosphate), which is then converted to ATP, ADP, and finally adenosine through dephosphorylation reactions. Breakdown of ATP: Adenosine is primarily formed in the body through the breakdown of ATP, which releases energy. ATP can be dephosphorylated stepwise through the action of various enzymes: ATP is first converted to ADP (adeno...
Read more